Summary
Definition
History and exam
Key diagnostic factors
- reduced urine production
- vomiting
- dizziness
- orthopnea
- paroxysmal nocturnal dyspnea
- pulmonary edema
- hypotension
- tachycardia
- orthostatic hypotension
- hypertension
- peripheral edema
- muscle tenderness
- limb ischemia
- seizures
- prostatic obstructive symptoms
- hematuria
- fever
- rash
- arthralgia/arthritis
- altered mental status
- signs of uremia
Other diagnostic factors
- nausea
- thirst
- flank pain
- abdominal distention
- abdominal bruit
- livedo reticularis
- petechiae
- ecchymoses
Risk factors
- advanced age
- underlying renal disease
- malignant hypertension
- diabetes mellitus
- myeloproliferative disorders, such as multiple myeloma
- connective tissue disease
- sodium-retaining states (e.g., congestive heart failure, cirrhosis, nephrotic syndrome)
- radiocontrast
- exposure to nephrotoxins (e.g., aminoglycosides, vancomycin + piperacillin-tazobactam, cancer therapies, nonsteroidal anti-inflammatory drugs, or ACE inhibitors)
- trauma
- hemorrhage
- sepsis
- pancreatitis
- drug overdose
- surgery
- cardiac arrest
- recent vascular intervention
- excessive fluid loss
- nephrolithiasis
- drug abuse
- alcohol abuse
- excessive exercise
- recent blood transfusion
- malignancy
- genetic susceptibility
- use of renin-angiotensin system inhibitors
- proton pump inhibitors
- herbal therapy
Diagnostic tests
1st tests to order
- basic metabolic profile (including blood urea nitrogen [BUN] and creatinine)
- ratio of serum BUN to creatinine
- urinalysis
- urine culture
- complete blood count
- fractional excretion of sodium
- fractional excretion of urea
- urinary eosinophil count
- venous blood gases
- fluid challenge
- bladder catheterization
- urine osmolality
- urine sodium concentration
- renal ultrasound
- chest x-ray
- ECG
Tests to consider
- antinuclear antibodies
- anti-DNA
- complement (C3, C4, CH50)
- anti-glomerular basement membrane antibodies
- antineutrophil cytoplasmic antibodies
- acute hepatitis profile
- HIV serology
- cryoglobulins
- erythrocyte sedimentation rate
- antistreptolysin-O antibody
- abdominal computed tomography or magnetic resonance imaging scan
- nuclear renal flow scan
- cystoscopy
- renal biopsy
Treatment algorithm
Contributors
Authors
Richard A. Lafayette, MD
Professor of Medicine
Nephrology Division
Stanford University Medical Center
Stanford
CA
Disclosures
RAL works as a consultant and researcher for Relypsa, Inc. Although unrelated to this topic area, RAL also works as a consultant for Fibrogen, Inc., Mallinckrodt, Inc., and Omeros, Inc., and as a researcher for Genentech, Inc., Mallinckrodt, Inc., GlaxoSmithKline, Inc., Rigel, Inc., Aurinia, Inc., and the NIH.
Acknowledgements
Dr Richard A. Lafayette would like to gratefully acknowledge Dr Sandra Sabatini, Dr Neil Kurtzman, and Dr Corey D. Ball, the previous contributors to this topic.
Disclosures
SS, NK, and CDB declare that they have no competing interests.
Peer reviewers
Garabed Eknoyan, MD
Professor of Medicine
Section of Nephrology
Department of Medicine
Baylor College of Medicine
Houston
TX
Disclosures
GE declares that he has no competing interests.
Dominic de Takats, MA, MRCP
Consultant Nephrologist
Nephrology
North Staffs Royal Infirmary
University Hospital of North Staffordshire
Stoke-on-Trent
UK
Disclosures
DdT declares that he has no competing interests.
Use of this content is subject to our disclaimer